CTLA4 and rheumatoid arthritis: Vice versa, the administration of CTLA-4-Ig (belatacept or abatacept) exerts beneficial effects on a range of autoimmune disorders such as airway inflammation [29, 30], rheumatoid arthritis [31], and dermal fibrosis [32] or to prevent rejection of allografts, particularly renal transplants [33].